AllianceBernstein’s Pfizer PFE Stock Holding History

AllianceBernstein’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$174M	Buy	6,973,956 +400,605	+6%	+$10.7M	0.06%	239
2025 Q4	$164M	Sell	6,573,351 -110,130	-2%	-$2.78M	0.05%	261
2025 Q3	$170M	Buy	6,683,481 +54,536	+0.8%	+$1.35M	0.05%	251
2025 Q2	$161M	Buy	6,628,945 +194,568	+3%	+$4.54M	0.05%	251
2025 Q1	$163M	Buy	6,434,377 +59,008	+0.9%	+$1.54M	0.06%	246
2024 Q4	$169M	Sell	6,375,369 -249,600	-4%	-$6.77M	0.06%	250
2024 Q3	$192M	Sell	6,624,969 -101,812	-2%	-$2.97M	0.06%	232
2024 Q2	$188M	Buy	6,726,781 +61,093	+0.9%	+$1.68M	0.07%	214
2024 Q1	$185M	Sell	6,665,688 -85,687	-1%	-$2.38M	0.07%	231
2023 Q4	$194M	Sell	6,751,375 -911,033	-12%	-$27.5M	0.07%	207
2023 Q3	$254M	Sell	7,662,408 -2,064,775	-21%	-$73M	0.11%	170
2023 Q2	$357M	Sell	9,727,183 -2,005,163	-17%	-$78M	0.15%	137
2023 Q1	$479M	Sell	11,732,346 -4,201,098	-26%	-$181M	0.21%	107
2022 Q4	$816M	Sell	15,933,444 -751,050	-5%	-$36M	0.37%	55
2022 Q3	$730M	Sell	16,684,494 -1,251,195	-7%	-$60.8M	0.35%	55
2022 Q2	$940M	Buy	17,935,689 +592,899	+3%	+$30.2M	0.43%	43
2022 Q1	$898M	Buy	17,342,790 +1,264,885	+8%	+$65.6M	0.35%	53
2021 Q4	$949M	Buy	16,077,905 +654,442	+4%	+$32.4M	0.34%	56
2021 Q3	$663M	Buy	15,423,463 +3,176,236	+26%	+$141M	0.26%	67
2021 Q2	$480M	Buy	12,247,227 +238,897	+2%	+$9.29M	0.19%	100
2021 Q1	$435M	Sell	12,008,330 -895,242	-7%	-$31.8M	0.19%	102
2020 Q4	$475M	Sell	12,903,572 -6,508,222	-34%	-$239M	0.22%	81
2020 Q3	$676M	Sell	19,411,794 -4,025,128	-17%	-$141M	0.36%	55
2020 Q2	$727M	Sell	23,436,922 -2,210,840	-9%	-$75.1M	0.43%	46
2020 Q1	$794M	Sell	25,647,762 -2,517,148	-9%	-$85.8M	0.57%	32
2019 Q4	$1.05B	Buy	28,164,910 +1,956,102	+7%	+$69.7M	0.6%	28
2019 Q3	$893M	Sell	26,208,808 -3,566,326	-12%	-$130M	0.56%	33
2019 Q2	$1.22B	Sell	29,775,134 -387,266	-1%	-$15.4M	0.76%	17
2019 Q1	$1.22B	Buy	30,162,400 +1,065,252	+4%	+$42.7M	0.79%	16
2018 Q4	$1.21B	Buy	29,097,148 +5,006,440	+21%	+$208M	0.89%	11
2018 Q3	$1.01B	Buy	24,090,708 +1,194,839	+5%	+$46M	0.66%	21
2018 Q2	$788M	Buy	22,895,869 +53,017	+0.2%	+$1.81M	0.55%	32
2018 Q1	$769M	Buy	22,842,852 +1,693,129	+8%	+$58.2M	0.56%	28
2017 Q4	$727M	Buy	21,149,723 +87,194	+0.4%	+$2.97M	0.52%	32
2017 Q3	$713M	Sell	21,062,529 -4,852,436	-19%	-$156M	0.53%	34
2017 Q2	$826M	Sell	25,914,965 -2,732,073	-10%	-$86.2M	0.64%	22
2017 Q1	$930M	Sell	28,647,038 -11,679,717	-29%	-$368M	0.74%	16
2016 Q4	$1.24B	Sell	40,326,755 -2,491,590	-6%	-$76.1M	1.04%	10
2016 Q3	$1.38B	Sell	42,818,345 -8,190,845	-16%	-$274M	1.16%	6
2016 Q2	$1.7B	Sell	51,009,190 -686,713	-1%	-$21.9M	1.47%	4
2016 Q1	$1.45B	Sell	51,695,903 -6,684,586	-11%	-$191M	1.24%	7
2015 Q4	$1.79B	Buy	58,380,489 +14,131,242	+32%	+$445M	1.52%	4
2015 Q3	$1.32B	Buy	44,249,247 +2,069,766	+5%	+$66.4M	1.13%	8
2015 Q2	$1.34B	Buy	42,179,481 +2,032,900	+5%	+$66.3M	1.11%	7
2015 Q1	$1.33B	Sell	40,146,581 -3,283,376	-8%	-$104M	1.07%	6
2014 Q4	$1.28B	Sell	43,429,957 -9,956,918	-19%	-$285M	1.07%	8
2014 Q3	$1.5B	Buy	53,386,875 +806,040	+2%	+$22.6M	1.26%	6
2014 Q2	$1.48B	Sell	52,580,835 -2,194,448	-4%	-$62.6M	1.25%	4
2014 Q1	$1.67B	Buy	54,775,283 +3,257,678	+6%	+$97.1M	1.44%	3
2013 Q4	$1.5B	Buy	51,517,605 +706,255	+1%	+$20.6M	1.34%	4
2013 Q3	$1.38B	Buy	50,811,350 +638,695	+1%	+$17.4M	1.37%	2
2013 Q2	$1.33B	Buy	+50,172,655	New	+$1.39B	1.42%	3

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

AllianceBernstein's PFE Position: Q1 2026 in Review

AllianceBernstein increased its Pfizer (PFE) stake by 6.1% in Q1 2026, buying an estimated $10.7M and bringing the position to 6,973,956 shares worth $174M. The position accounts for 0.06% of the portfolio, ranked #239.

AllianceBernstein first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.79B in Q4 2015. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

AllianceBernstein held 6,973,956 shares of Pfizer worth $174M as of Q1 2026.
AllianceBernstein bought 400,605 Pfizer shares in Q1 2026, an estimated $10.7M.
Pfizer made up 0.06% of AllianceBernstein's portfolio in Q1 2026, its #239 holding.
AllianceBernstein first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
AllianceBernstein's Pfizer position peaked at $1.79B in Q4 2015.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.